NCT00003483View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Patients With Meningioma

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Meningioma
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Adults with a meningioma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER